QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. I. A STUDY OF A BATTERY OF TESTS DESIGNED TO EVALUATE IN PART THE NEUROLOGICAL FUNCTION OF PATIENTS WITH MULTIPLE SCLEROSIS AND ITS USE IN A THERAPEUTIC TRIAL * by Tourtellotte, Wallace W. et al.
QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. I. A 
STUDY OF A BATTERY OF TESTS DESIGNED TO EVALUATE 
IN PART THE NEUROLOGICAL FUNCTION OF PATIENTS WITH 
MULTIPLE SCLEROSIS AND ITS USE IN A 
THERAPEUTIC TRIAL* 
Wallace W. Tourtellotte, Armin F. Haerer,? John F. Simpson, 
J. W. Kuzma,$ J. Sikorski 
Department of Neurology and the Department of Biostatistics, 
University of Michigan, Ann Arbor, Mich. 
The long term goal of this study is to design a battery of objective clinical neuro- 
logical tests which are appropriate for patients with multiple sclerosis, so that the 
results of therapeutic trials in this disease might be evaluated with less bias and 
hence be more valid. In this study some of the conventional neurologic tests used 
by clinicians’, to evaluate functional capacity of multiple sclerosis patients have 
been replaced in part by methods which lend themselves to more objective 
measurements. 
Since no previous studies along this line have been reported, it was necessary to 
design experiments on normal individuals and patients with multiple sclerosis to 
determine some of the limitations of the battery of tests before undertaking a 
therapeutic trial. 
METHODS 
The battery of clinical quantitative neurological tests used in this study is shown 
in TABLE 1. The test battery consisted of three parts, visual acuity and functions of 
the upper and lower extremities. The details for the administration of this battery 
of neurologic tests were modified somewhat during the stages of experimentation 
with normal subjects as new information was obtained. The final form of instruc- 
tions for the examiner used on all the multiple sclerosis patients was as follows: 
Description of the Quantitative Clinical Tests 
Visual acuity with glasses. The Standard Snellen visual acuity test was used; the 
corrected vision was measured in each eye in turn. The visual acuity is established 
by finding a line on the chart for which the patient makes no more than three errors 
and the next larger print is read without error. Deductions were made for incor- 
rectly identified letters. A conversion table was prepared for each possible response; 
for example, 20/25-3 corrected vision was equivalent to 0.75 visual acuity. 
When the patient’s visual acuity was so impaired that the largest letters on the 
Snellen reading chart could not be identified, the Lebensohn reading card was used. 
The visual acuity was estimated by permitting the patient to use the card ad lib; 
that is, he could use peripheral vision at any distance. A conversion table was pre- 
pared for each letter size similar to the Snellen visual acuity test conversion table 
except that deductions were not made for incorrectly identified letters and that no 
consideration was given for distance between eye and letters. 
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TABLE 1 
LIST OF CLINICAL QUANTITATIVE N UROLOGICAL FUNCTIONS TESTED IN THIS STUDY 
I ,  Visual acuity 
11. Functions of the upper extremity 
A. Hand speed 
B. Hand coordination 
C .  Strength (grip, wrist, deltoid) 
D. Fatigue 
1. Hand speed 
2. Hand coordination 
3. Grip strength 
1. Finger vibration 
2. Finger two-point discrimination 
E. Sensation 
111. Functions of the lower extremity 
A. Station stability 
1. Eyes open 
2. Eyes closed 
B. Foot speed 
C. Strength (foot and hip flexor) 
D. Fatigue 
1. Foot speed 
2. Hip flexor strength 
E. Vibratory sense (toe) 
On subsequent testing the subject was instructed to read the line which was his 
previous best score. 
Speed and fatigue of hand. For this an Adam-Clay 9 key laboratory counter was 
used. The subject seated in a standard chair and table arrangement was asked to 
strike the same button with his index finger for 5 ,  10, 20 and 30 consecutive sec- 
onds, as fast as possible. The right hand was tested before the left hand. (In all 
subsequent tests the right side was tested first.) The rest period between trials was the 
time required to record the result. The 10-second interval (second trial) is used in 
subsequent analyses as the speed of the hand tests, and the 30-second interval 
(fourth trial) divided by three is referred to subsequently as hand speed fatigue test. 
Coordination and fatigue of hand. An Adam-Clay 9 key laboratory counter was 
used for these tests. The subject was instructed to strike the white keys only, from 
left to right with the index finger, for 5 ,  10, 20 and 30 consecutive seconds as fast 
and as accurately as possible. All the counts (red and white keys) registered on the 
counter are recorded; the rest period between trials was the time to record these 
data. 
Frequently a subject will strike a red key by mistake. In order to get a score which 
will reflect coordination more appropriately, an adjusted score is obtained by sub- 
tracting twice the score recorded for the red keys from the score recorded for the 
white keys. Occasionally a negative net score will result from this correction; such 
a score was arbitrarily set to zero. 
The adjusted 10 second test score (second trial) is referred to in subsequent 
analyses as the test for coordination of the hand, and the adjusted 30 second test 
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score (fourth trial) divided by three is referred to subsequently as the test for fatigue 
of hand coordination. 
Grip and fatigue strength. The Jamar hand dynamometer was used for this; the 
variable grip handle position was maintained in the second position. The subject 
was instructed to maintain his grip as high on the handle as possible for five seconds. 
The rest period between the five trials consists of the time to record the reading 
and reset the dynamometer dial. The first trial is referred to as grip strength and 
the fifth trial, as grip strength fatigue. 
Wrist strength. A calibrated Newman myometer (60 pound gauge) with attached 
handle pushers was used for all subsequent strength tests. The wrist was positioned 
by putting the subject's arm on the arm of the standard chair so that the wrist in 
maximum dorsiflexion was at the end of the arm of the chair; the hand was in the 
form of a fist. The instrument pad was centered over the third metacarpal; force 
was then applied at right angles to the dorsum of the hand. The subject generally 
gives away suddenly. The rest period between the two trials consisted of the time 
to reset the dial and record the datum. The fist  trial was used as the wrist strength 
unless the patient did not perform the test properly; under these circumstances the 
second trial result was considered 
Deltoid strength. A Newman myometer as described was used. The deltoids were 
positioned for the test by flexing the arm at the elbow and abducting the upper 
arm to a right angle. The instrument pad was placed at right angles over the lateral 
aspect of the elbow joint. The rest period between the two trials consisted of the 
time to reset the dial. The first trial was used as the deltoid strength unless the pa- 
tient did not perform the test properly; under these circumstances the second trial 
result was considered. 
Finger vibratory sensibility. A Biothesiometer (Model PVD) which vibrates at 120 
cycles per second was modified to double its range (0 to 100 microns). The subject 
was instructed to place the pad of second finger down onto the vibrator, so that 
the fingerprint whorl was over the center of the vibrator. The subject was given a 
recognizable stimulus, then beginning with zero voltage, the amplitude of vibration 
was increased gradually by turning the voltage knob evenly and slowly, with the 
examiner watching the voltage dial, until the subject reported his first perception 
(threshold) of vibration. This procedure was repeated three times and the threshold 
values converted to microns and averaged to arrive at a score. 
If a patient was found to have a very high threshold, his responses appeared more 
consistent if the voltage was advanced at five volt steps rather than smoothly. 
Finger two-point discrimination. Sweet's two point compass calibrated in milli- 
meters (mm.) was used. The subject was given a recognizable stimulus of > 10 mm. 
to the index finger across the pad at the center of the fingerprint whorl. The 
stimulus was decreased by about one mm. per trial, until the subject gave three 
consecutive responses of perceiving one point at the same measurement. If this was 
the threshold value, the subject correctly recognized the next increment of one mm. 
Station stability. In a corner with grab supports to prevent falling, the subject 
was asked to stand on one foot without touching the walls with eyes open. The test 
ended when the patient touched to catch his balance or when he performed the 
test for 30 seconds. The best of three tests was taken as the station stability with 
eyes open. 
The test was carried out in a similar fashion with the eyes closed 
Speed and fatigue of foot. A foot pedal similar to a gas pedal on a car was con- 
structed to measure the speed of foot tapping. The subject was instructed to tap 
the foot pedal, with sufficient force to have an attached counter register it, for 5, 
10, 20 and 30 consecutive seconds, as fast as possible. For proper positioning of 
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the foot on the pedal platform the heel should be directly over the pivot point. The 
test was demonstrated to the subject and a trial of several seconds was permitted. 
The rest period between trials was the time required to record the results. The 10 
second interval (second trial) is used in subsequent analyses as the speed of the 
foot, and the 30 second interval (fourth trial) divided by three is referred to as foot 
speed fatigue. 
Foot strength. The Newman myometer described above was used for this test. 
The foot was positioned by placing the foot in maximum dorsiflexion with the heel 
in a groove in a two inch wooden foot platform. The foot platform was notched to 
fit around the chair legs, so as to prevent it from sliding during the test. The instru- 
ment pad was placed over the second, third and fourth metatarsals; force was 
applied at a right angle to the dorsum of the foot. The rest period between two trials 
consisted of the time to reset the dial and record the reading. The majority of normal 
males used in this study could resist a force of 84 pounds which is the maximum 
reading on the myometer. The first trial was used as the strength of the dorsiflexion 
of the foot unless considered unreliable due to lack of patient cooperation; under 
these circumstances the second result was considered. 
Hipflexor strength and fatigue. The Newman myometer described above was used 
for these tests, The hip flexors were positioned by having the subject slide forward 
in the chair and then the extended leg was raised to the horizontal just before test- 
ing. The instrument pad was placed over the ankle and force was applied at right 
angles until the heel contacted the floor; the reading was noted just before the heel 
touched the floor, since the gauge is jarred by this contact. The rest periods between 
the five consecutive trials consisted of the time to record the reading and to reset 
the dial. Rarely can an individual resist 84 pounds, which is the maximum value 
on the myometer. The first trial was referred to as hip flexor strength and the fifth 
trial as the hip flexor strength fatigue. 
Total students 
per cent right handed 
TABLE 2 
GENERAL CHARACTERISTICS OF THE NORMAL COLLEGE STUDENTS USED IN THIS 




20 17 10 8 
95 88 90 100 
Normal male 
medical students 
Characteristics 1 I Group 1 I Group2 I right handed 
Average age in years 
(range) 
Weight in pounds 
(range) 
21 24 31 26 
(19-22) (1 8-37) (22-38) (22-34) 
125 165 177 173 
( 1  10-1 50) (135-202) (140-230) (140-205) 
Height in inches 
(range) 
64 69 69 71 
(60-68) (67-74) (68-73) (68-76) 
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TABLE 3 
USED IN THIS STUDY TO EVALUATE THE APPLICATION F 
THE PROPOSED TEST BATTERY 
GENERAL CHARACTERISTICS OF THE AMBULATORY MULTIPLE SCLEROSIS PATIENTS 
Characteris tics 
Total patients 
Per cent females 
Per cent right-handed 
Average age (years) 





Female : Mean 
Range 
Male : Mean 
Range 
Height (inches) 
Female : Mean 
Range 
Male : Mean 
Range 
Duration of disease (at time of examination) (yea] 
Mean 
Range 
Per cent of patients who required appliances 
to walk at time of examination 
Average Kurtzke total disability score 
at time of examination 
Diagnostic grouping' (per cent) 


















































37 (in relapse) 
52 
11 
The 40 patients reported in this TABLE are the same as those used in the therapeutic trial; 
only the data obtained at the initial examination, that is, before the drugs were administered 
are shown in this TABLE. 
*Group I: Multiple sclerosis manifested by bouts. The patient may be either in a relapse or 
a remission at the time of the examination. Group 11: Multiple sclerosis manifested by bouts 
followed by a chronic phase. The patient may be stationary or progressively worsening; relapses 
are rare. Group 111: Multiple sclerosis manifested by a chronic course. Patient may be stationary 
or progressively worsening; relapses are rare. 
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Toe vibratory sensibility. The Biothesiometer and the technique of using the equip- 
ment was the same as described above for finger vibratory sensibility. The subject’s 
foot was placed flat on the floor and then the vibrator was positioned at the base 
of the first toe on the joint interspace. In patients with very impaired vibratory sense 
the sensation was referred; for example, “in my leg.” Only sensation perceived in 
the finger or at the base of the toe were recorded. 
As well as carrying out all the above tests in a given order on patients, a routine 
neurological examination was done in order to score the patient’s neurological func- 
tion according to Kurtzke’s system.2 The entire examination took about 45 minutes. 
Description of Normal Subjects 
In TABLE 2 are presented the general characteristics of the normal college students 
used in this study to determine the limitations of the proposed test battery. The 
individuals were paid volunteers from the student body of the medical school or 
the school of nursing (females); they were judged free of disease in the past or at 
present by history. 
Description of Multiple Sclerosis Patients 
The definition of multiple sclerosis beyond reasonable clinical doubt was based 
upon the criteria presented in another report in this m~nograph .~  Also the patients 
used in this study were selected after consideration of the criteria for exclusion of 
a patient from a therapeutic trial presented in Schumacher’s r e p ~ r t . ~  In TABLE 3 
are presented the general characteristics of the ambulatory multiple sclerosis patients 
used in this study. 
Design of the Therapeutic Trial 
The design of the therapeutic trial also followed closely that laid down by 
Schumacher’s ~ommi t t ee .~  We divided the medical staff into two teams. The 
therapists were Armin F. Haerer and John F. Simpson. They selected the patients 
by a preprinted set of rules3 and also prescribed the drugs in a predetermined 
random fashion; the patients were unaware of what drug they were receiving. The 
therapists were also responsible for patient care. The only responsibility the 
examiner (Wallace W. Tourtellotte) had in this study was to carry out the quantita- 
tive neurological examination, as well as score the neurological function based on 
a classical neurological examination according to Kurtzke;‘ he only saw the patients 
at the time of the examination, and he had no knowledge of the kind of medica- 
tions the patients were receiving. Effort to eliminate bias at the patient and examiner 
level was taken. 
In TABLE 4 are given the general characteristics of the ambulatory multiple 
sclerosis patients used in the therapeutic trial. 
TABLE 5 shows the time when the examinations were carried out and the dosages 
of the five treatments used. Immediately after the initial neurological examination 
the treatment was started. For example, Soh-Medrol,@ 160 mg. was given every 
day intramuscularly for seven days, then the second quantitative neurological 
examination was carried out. The Soh-MedrolB was then tapered at the rate of 
25 mg. every day for six days. At this point the third neurological examination 
was carried out. These large dosages of steroids were recommended to us by 
Robert F. Kibler; his experiences are also reported in this rnon~graph .~  
In addition to the above medications the patients were all placed on a 900 mg. 
sodium diet which contained approximately 1,800 calories. Potassium chloride was 
given one gram three times a day and Maalox,@ Gelusil@ or Amphojel,@ 30 mL in 
between meals and at bedtime. 
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All patients were given appropriate physical therapy in the morning and after- 
noon under the dirxtion of professional therapists. Other than this the patients 
were up ad lib and encouraged to be at full activity. 
TABLE 4
USED IN THE THERAPEUTIC RIAL 
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Range 
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TABLE 5 
THE FIVE TREATMENTS USED 
TIME OF THE QUANTITATIVE N UROLOGICAL EXAMINATION AND 
__ -
I 
n E  




Treatment for 1st week 
Vitamin B,, : 1000 pgm., Q.D., I.M. 
Depo-acth@ : 120 mg., Q.D., I.M. 
Soh-Medrol@ : 160 mg., Q.D., I.M. 
Medrol@* : 160 mg., Q.D., Oral 
AlphadroPt : 60 mg., Q.D., Oral 
‘MedroP : 6 a Methyl Prednisolone. 
tAlphadrol@ : 6 a Fluoro Prednisolone. 
S 
e E  
o a  
n m  
d 
c x  
Treatment for 2nd week 
1000 pggm, Q.D., I.M. 
Decrease 20 mg., Q.D. 
Decrease 25 mg., Q.D. 
Decrease 25 mg., Q.D. 
Decrease 10 mg., Q.D. 
On the morning of the quantitative neurological examination physical therapy 
was postponed until after the examination. As a further effort to standardize con- 
ditions, patients were brought to the examining room in a wheel chair. 
Statistical Methods 
The statistical methods used in this study have been presented in Kuzma’s doc- 
toral t h e s i ~ , ~  and will also be presented elsewhere.6 A 4 X 4 Graeco-Latin square 
design with two observations per cell was used to estimate the variability of learn- 
ing and fatigue of the subjects and to determine if there was a difference between 
observers. 
Kuzma5 also discusses the problems related to correlated observations such as 
that which resulted from repetitive testing in an attempt to produce fatigue. In the 
present study fatigue is presented as the last trial of a series, whereas Kuzma has 
utilized a more powerful statistic (time-response curves). 
RESULTS AND DISCUSSION 
The battery of clinical quantitative neurological tests listed in TABLE 1 has been 
applied to normal individuals, to untreated patients with multiple sclerosis and to 
patients participating in a therapeutic trial. 
Normal Individuals 
Since no one has used a similar battery of clinical quantitative neurological 
tests, we designed experiments on normal college students to determine the limita- 
tions of the battery of tests and to redefine the tests, if necessary. 
Some comments on this battery of tests which will probably be extended when 
more normal individuals are examined will be presented first. It was found that 
with the speed tests, such as hand speed, hand coordination, and foot speed, 
a five-second trial served as a warm-up period. Along the same line, when station 
stability was tested, especially with the eyes closed, a bad start could result in a 
low score; therefore, it was decided to choose the best score out of three trials. 
The Newman myometer (60 pound gauge) which can only measure 84 pounds 
did not permit evaluation of strength of dorsiflexors of the foot in the majority of 
normal male subjects and occasionally the hip flexor strength as defined for this 
study. However, we continued to use the myometer since this was not the case for 
normal females or any of the multiple sclerosis patients. 
a
TABLES 6, 7 and 8 present the results of the test battery done on normal indi- 
viduals; the general characteristics of the normal individuals were shown in TABLE 
2. The data in columns 2, 3, and 4 in TABLES 6, 7 and 8 were some of the first we 
obtained; they were obtained by John Sikorski under the direction of Wallace W. 
Tourtellotte. The data in column 2 of TABLES 5 ,  6 and 7 are the only normal 
female data we have. The data in columns 3 and 4 were composed of 27 different 
normal male medical students (17 in group 1 and 10 in group 2); they were exam- 
ined four months apart. The agreement between the two samples was considered 
good. 
It can be gleaned from these TABLES (7 and 8) that performance of normal 
females differs in certain respects from normal males; the most marked differences 
appear in the strength tests. 
The data in TABLES 6, 7 and 8 also suggest that certain tests of the battery are 
sensitive enough to detect handedness in both females and males. Speed of hand 
and grip strength appear to differ most when the right hand is compared to the 
left. We have also analyzed the data separating the few left-handers from the data 
presented in TABLES 7 and 8 and the differences become even more obvious. 
In TABLES 6, 7 and 8 are also presented some data obtained by Wallace W. 
Tourtellotte (data in last columns). These data are presented separately for several 
reasons, even though the sample size is small and hence subject to errors inherent 
in testing small samples. First, these data were obtained by the latest techniques; 
second, the examiner (Wallace W. Tourtellotte) who made these observations is the 
same examiner used in the therapeutic trial to be reported below; third, in ana- 
lyzing the data in the therapeutic trial we discovered that if normal results for a 
given test (within mean of WWT data minus two standard deviations) were 
analyzed separately from abnormal results (outside mean of WWT data minus 
two standard deviations) a number of significant differences was disclosed; and 
fourth, by inspection most of the results obtained by WWT do not differ too 
much from those obtained by John Sikorski (columns 3 and 4, TABLES 6, 7 and 8) 
except when the technique of carrying out the test was changed drastically. 
Also shown in  TABLES^, 7 and 8 are coefficients of variation for most of the 
mean test results. The coefficient of variation (standard deviation times 100 divided 




Mean (C.V.* %) 
Right Left 




8 Normal male 
Group 1 Group 2 right handed 
(17 students) (10 students) medical students 
W.W.T. data 
Mean (C.V. %) Mean (C.V. %) Mean (C.V. %) 
Right Left Right Left Right 
1.12 (30) 1.06 (30) - - 1.31 (39) 
TABLE 6 
VISUAL ACUITY (CORRECTED WITH GLASSES) OF NORMAL COLLEGE STUDENTS 
*C. V. means coefficient of variation; standard deviation X 100/mean. 
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TABLE 7
USED IN THIS STUDY TO DETERMINE SOME OF THE LIMITATIONS 
OF THE PROPOSED TEST BATTERY 
489 




Mean (C.V. %) 
Right Left 
Tests 
8 Normal male 
right handed 
medical students 
W. W.T. data 
Mean (C.V. %) 
Right 
Speed of hand (strokes 
per 10 seconds) 
2nd trial 
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2nd trial 



























Two point (mm.) 
40(16) 46(22) 
35 (13) 40 (19) 
99(17) loO(26) 
71 (25) 77 (22) 
53 (21) 58 (16) 
- 58 (13) 
0.1 (69) 0.1 (41) 



























L.8 ( 9) 
I 
*Grip fatigue test used on these individuals differed from that defined in the METHODS; 
grip was only maintained two seconds, instead of five, for each trial. 
value from one test to another because it is calculated as a percentage of the 
mean. For example, in the row entitled “speed of hand second trial” note that the 
coefficient of variation for females was 10 per cent for the right hand and for data 
obtained by WWT on normal males it was seven per cent; this was considered 
good agreement. 
The highest coefficients of variation were obtained when vibratory sense was 
measured; 41 per cent for the finger tip and 70 per cent for the base of the great 
toe. Greater attention to details of conducting the test has not decreased this 
variation much. It is our impression that the decision of each subject as to what 
constitutes vibration threshold must be different; that is, it is not due to faulty 
technique of conducting the test. Furthermore, since the vibratory stimulus 
perceived is very small, on the average 0.1 for the index finger tip, a subject has to 
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TABLE 8
FUNCTION OF THE LOWER EXTREMITIES OF NORMAL COLLEGE STUDENTS 
USED IN THIS STUDY TO DETERMINE SOME OF THE LIMITATIONS 




























Fatigue (5th trial) 
Sensation 
Vibration (microns) 
























8 Normal male 
Group 1 
W.W.T. data 
Right Left Right TF 
0.4(60) 10.4(64) 10.8(72) 
Left I Right 
--t---- 
I 
0.6(107 I 0.5(70) 
*Hip flexor strength test used on these individuals differed from that defined in the METHODS; 
in the sitting position the hip and knee were flexed and then pressure through the myometer 
was applied at right angles directly over the knee. 
be very accurate or else it will appear statistically that his perception is erratic. For 
example, when on duplicate testing scores of 0.1 and 0.15 microns were obtained 
it would appear statistically that his performance was highly variable, but clinically, 
since the stimulus was small, this was good agreement. 
In TABLE 6 are shown the coefficients of variation for visual acuity; it is our 
impression that the high coefficient of variation of 39 per cent obtained by WWT 
may not be due to faulty technique of conducting the examination, but may be an 
expression of the variability of this sample which differed from the other three 
samples. 
It might be of some interest to present coefficient of variations on two cerebro- 
spinal fluid constituents obtained in our laboratory for comparison to those 
obtained by the proposed test battery. A modified biuret total protein procedure 
has a coefficient of variation of 5.1 per cent on replicate determinations of the 
same sample; when the coefficient of variation for 137 normal college students was 
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Week 
Test 1 




Mean (C. V. %) 
calculat&d it was found to be 27 per cent (10.2 standard deviation X 100/38.2 mg./ 
100 ml.). Moreover, the coefficient of variation for counting normal white cells in 
cerebrospinal fluid (< 4.7 white cells / cu. m m )  was 20 per cent on replicate 
determinations of the same sample and 61 per cent (1.0 X 100/1.7) for the same 
137 normal college students used to determine the normal total protein value. It 
would appear on comparison with these laboratory tests that the coefficients 
of variation presented in TABLES 6, 7 and 8 for the proposed battery of neurologi- 
cal tests are reasonable. 
The next experiment done was to determine if normal subjects on repetitive 
testing fatigued, that is, obtained significantly lower scores or learned how to do 
the tests better, that is, obtained significantly higher scores. The first data we 
obtained along this line were done on the females and males (TABLES 6, 7 and 8 
group 1 and 2) by John Sikorski; only the initial data are shown. For females and 
group 1 males he repeated the examination within two days. For group 2 males he 
repeated the examination for the next two days and again after three days of rest. 
between the first and second examinations for 
females was tested with a double-tail F-test. The variances for grip strength for the 
right hand and hip flexor strength were significantly different (p < 0.05). Since the 
mean differences between the first and second examination were less than five per 
cent, these changes were considered only technically significant. 
The equality of variance for group 1 males was tested statistically in the same 
manner as mentioned above. Only finger vibration sense for the right hand showed 
significantly different variances. This again was thought to be a technically signifi- 
cant difference. 
For the group 2 males equality of variances between the four examinations was 
also tested. The variance for the left foot strength was significant at the five per 
cent level. As mentioned earlier, this may be explained by the constant reading 
recorded when the limit of the instrument was exceeded. 
These preliminary data on repetitive testing done one to four days apart on the 
same normal individuals utilizing the paired Student test5 indicated that learning 
and fatigability in the normal individuals was not sufficient to be statistically 
significant. 
A more powerful design (4 x 4 Graeco-Latin square) to test if learning and 
fatigability on repetitive testing are significant factors was suggested by K ~ z m a . ~ ? ~  
Eight normal right-handed medical students were tested every day for four days, 
then after one week of rest they were reexamined every day for another four days. 
The first week’s data were averaged for a given test and compared to the second 
week‘s data. TABLE 9 presents the only neurologic test which had significantly 
The equality of variances5~ 
~~ 
Hip Flexor Strength 
(pounds) 
48 (16) 58 (13) 
TABLE 9
ONLY NEUROLOGIC TEST WITH SIGNIFICANTLY DIFFERENT MEANS FROM WEEK 1 TO 
WEEK 2: 8 NORMAL MALE RIGHT-HANDED MEDICAL STUDENTS 
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different means between weeks; the hip flexor strength increased 120’per cent 
from week 1 to week 2. It is our impression that this improvement was due 
to organized daily exercise (five trials per day for eight days) on a muscle group 
sensitive to training; therefore therapeutic trials should be so designed as to avoid 
“training” of the hip flexors; that is, perhaps, weekly examinations instead of 
daily examinations. We have concluded from this study that the proposed test 
battery is not influenced by repetition of examinations on normal individuals, 
except hip flexor strength which increases with repetitive testing. 
The next question asked was as follows: Can different examiners get the same 
results with the proposed test battery? Two neurologists and two physical thera- 
pists were selected as examiners and the same 4 x 4 Graeco-Latin design employing 
eight normal medical students mentioned above was used to answer this question. 
The examiners initially were instructed by Wallace W. Tourtellotte until he felt 
that they could carry out the tests adequately. Each of the four examiners exam- 
ined two of the subjects on four subsequent days and after one week the entire 
program was repeated. The data presented in TABLE 10 show the neurologic tests 
having significantly different examiner means. For example, in the row entitled 
wrist strength note that physical therapist 2 obtained a value of 47 pounds, 
whereas the other three examiners ranged from 58 to 60. It was apparent that this 
examiner was not performing the test in the same way as the other examiners. 
On the other hand, what she was finding was consistent since the coefficient 
of variation was similar to the others, 12 and 9 per cent, respectively. 
In view of these data we reviewed the techniques of performing the examination 
I I 
TABLE 10 
RIGHT-SIDED ATA: 8 NORMAL MALE RIGHT-HANDED MEDICAL STUDENTS 
LIST OF NEUROLOGICAL TESTS HAVING SIGNIFICANTLY DIFFERENT EXAMINER MEANS 
I 
4. F. H.; Junior 
Neurologist 
Mean 
(C. v. W) 
Tests Physical Physical 
Therapist 1 Therapist 2 
Mean Mean 
( C .  v. %) (C. v. %) 
W. W. T.; Senior 
Neurologist 
Mean 
(C. v. %) 
Upper Extremity 
Wrist strength (pounds) 
Deltoid strength (pounds) 
Two-point discrimination 







Speed of foot 
(Strokes per 10 seconds) 
Hip strength (pounds) 
Hip strength fatigue 









60(  9) 47(12)* 
63 (12) 53 (15) 
c ( 1 5 )  2.6(13) 
Examiners 
48(W 
- 53 (14) 
53( 9) 50(10) 
56(13) 5l(14) 
0.16(76) 1 m ( 2 4 )  1 0.16(76) 
53 (14) 57(14) g ( 1 6 )  
0.6(32) I u ( 1 7 )  I 0.6(31) 
*Underlined data were found to be responsible for significant observer means. 
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and retrained all the examiners. This time the examiners met every day for one hour 
and tested each other; at the end of five days we were all getting similar results. 
After we were all retrained we examined another group of 12 normal right- 
handed medical students; only those tests shown in TABLE 10 were performed 
TABLE 11 shows that only three neurologic tests remained significantly different 
among the four examiners. Examination of wrist strength apparently is “tricky” and 
requires a skill which may be difficult to teach. On the other hand, it is our 
impression that the significant differences discovered on retesting for finger two- 
point discrimination and finger vibration sensibility are technical dfferences, that 
is, the dfferences between the means should be disregarded, since they are so 
small. It should also be noted that the coefficients of variation decreased markedly 
for vibration sense for three of the four examiners on retesting. This was probably 
due to the fact that we decided to carry out this test on the center of the index 
fingerprint whorl. It is our impression that the majority of ladies who are strong 
enough to be physical therapists who carry out muscle testing are strong enough to 
carry out our proposed muscle tests. We have concluded from this portion of the 
study that the proposed battery of neurological tests can be performed by neurol- 




(C. v. %) 
60( 9) 
- 42 (12) 





LIST OF NEUROLOGICAL TESTS HAVING SIGNIFICANTLY DIFFERENT 
RIGHT-SIDED ATA: 8 NORMAL MALE RIGHT-HANDERS 




(C. v. %) 
- 41 (12) 






Wrist strength (pounds) 
Initial 
Retest 
Two-point discrimination on 
Index finger tip (mm.) 
Initial 
Retest 
Vibration sense on index 
Finger tip (microns) 
Initial 
Retest 
W. W. T. 
Mean 
(C.  v. %) 
2.6 (13) 




A. F. H. 
Mean 
(C. v. %) 
2.8 (12) 
- 2.8 (13) 
0.16 (76) 
0.08 (41) 
Ambulatory Multiple Sclerosis Patients 
The next series of experiments were done to provide information on the applica- 
bility of this test battery to patients with multiple sclerosis. Patients with Kurtzke 
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total disability score* of 6* or less (at the time of admission) were used in this study, 
with the exception of patients who had relapsed from a score of 6 or less to a score 
of 7 or more, eight weeks before admission to the study. 
The general characteristics of the two groups of patients, 10 outpatients and 40 
inpatients, studied are shown in TABLE 3. In general the neurological health 
of the outpatients was better than the inpatients; note the mean Kurtzke total 
disability of 4 and 5 for outpatients and inpatients, respectively. This may be due 
in part to the fact that outpatients were purposely selected because their neuro- 
logical status by history had not changed for eight or more weeks prior to the exami- 
nation. On the other hand, the 40 inpatients reported here are the same patients 
as those used in the therapeutic trial; 37 per cent of these patients had had 
a worsening of their neurological status by history eight or less weeks prior to the 
examination. 
We encountered some problems when the proposed test battery was applied to 
patients with multiple sclerosis. The manner of quantitating the visual acuity when 
dense central scotoma existed was mentioned under METHODS. Only the hand 
coordination test requires visual acuity of 0.1 (20/200) or better in one eye; only 
two patients out of 50 could not perform this test because their visual acuity 
was < 0.1. 
One patient on testing right-hand speed had noticeably variable speed during 
each of the four trials especially the 20 and 30 second trial; “He seemed to break 
into a sudden burst of speed.” 
In station stability testing occasionally the patient was so weak he was unable 
to raise his leg to test one-legged station stability; for such patients we arbitrarily 
assigned a score of 0. In future experiments we will also include station stability 
in both feet with eyes open and closed. 
In some patients muscle strength testing posed problems. Frequently, zero 
strength was recorded. In two patients out of 50 involuntary leg jerks and cramps 
were induced with hip flexor strength (also fatigue) testing. In another patient 
ankle clonus interfered with the foot strength test. 
In one patient (same patient mentioned above) in this series clonus interfered 
with the foot-speed test. It was possible to continue these tests in spite of these 
involuntary movements. 
When a patient had an increased sensory threshold either for two-point discrimi- 
nation or vibration, it was difficult for him to respond reliably; it appeared as if 
he had broadened his threshold, that is, there was a wide scatter of responses. 
Also in the lower extremities toe vibration sense was not elicited in eight patients 
out of 50 when they were stimulated with 100 microns; they were assigned values 
of 100 arbitrarily. 
It should be mentioned that patient cooperation and motivation to perform the 
proposed test battery to the best of their ability appeared good. 
*Definition of Kurtzke* total disability score 4 named by him Relatively severe dysfunctions 
in an arnbulatorypatient is as follows: The dysfunction should not be so severe as to prevent 
the ability to work and/or carry on normal activities of living and to use public transportation. 
Definition of Kurtzke total disability score 5 named by him Severe dysfunction in an 
arnbulatorypatient is as follows: Usually patient cannot work, but he should be up and about 
all day; he can walk unaided several blocks; also severely decreased visual acuity was included 
in this category. 
Definition of Kurtzke total disability score 6 named by him Assistance required for walking 
is as follows: Usually the patient cannot work; but he should be up and about most of the 
day; he can walk short distances with aid of canes, crutches, and short double upright 
day; he can walk short distances with aid of canes, crutches, and short double upright braces; 
this category did not include patients requiring fulltime use of a walker or paraplegics. 





% of Within 
normal Abnor- patients all range ma1 who were 
a bnor ma1 
Over- 
The data dealing with the untreated ambulatory multiple sclerosis patients are 
presented in TABLES 12 through 15. Since all the examinations were carried out by 
Wallace W. Tourtellotte, it was decided to use data obtained by this examiner on 
eight normal volunteers as a basis for comparison; this is recorded in the second 
columns of TABLES 12, 13 and 14. 
Also in TABLES 12, 13 and 14 the data on multiple sclerosis patients have been 
stratified into those patients who fell within the range (mean k 2 standard devia- 
tions) and those who fell outside this range. In this study patients only fell on the 
subnormal (or abnormal) side of the range. The outer limit of the range for 
a given test was determined by subtracting two standard deviations from the mean 
of WWT data, except for two-point discrimination and vibratory sensibility in 
which the threshold was raised, so that a mean plus two standard deviations was 
used. For example, in TABLE 13 the hand speed was 77 strokes per 10 seconds; the 
lower limit of the range was 66 (77- 77 X 0.14). Under the assumption that these 
observations are normally distributed it is expected that about 2.5 per cent of the 
subjects will fall below 66. When this cut off point of 66 was applied to out- and 
inpatients, 90 and 87 per cent were abnormal, respectively. 
This type of analysis has several justifications. It is reasonable to expect in 
a therapeutic trial that patients who are normal will not be affected by the therapy; 
on the other hand, it is reasonable to assume that if a medication is effective 
it should improve the function of those tests which are subnormal. 
This technique of separating the normal functions from the subnormal has 
another advantage; it can decrease the variance and hence significant differences 
can be discovered with fewer observations. 
TABLE 12 
VISUAL ACUITY (CORRECTED WITH GLASSES) OF RIGHT EYE OF AMBULATORY 
UNTREATED MULTIPLE SCLEROSIS PATIENTS USED IN THIS STUDY TO 
EVALUATE THE APPLICABILITY OF THE PROPOSED TEST BATTERY 
























Prior to now we were unable to stratify mathematically a group of patients into 
those with normal and those with subnormal function. It is realized that the 
dividing point between normal and subnormal function at present may not be a 
valid one, since we do not think that we have a large enough “normal” group of 
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TABLE 15 
PER CENT OF UNTREATED AMBULATORY MULTIPLE SCLEROSIS PATIENTS 
WITH ABNORMAL RESULTS FOR THE VARIOUS TESTS (RIGHT SIDE) 










~ ~ ~~ 
Station stability (eyes open and closed) 
Foot speed (also fatigue) 
Foot strength 
Toe vibration sense 
Hand speed (also fatigue) 
Deltoid strength 
Wrist strength 
Hip strength (also fatigue) 
Finger two point discrimination 
Finger vibration sense 
Hand coordination (also fatigue) 
Grip strength (also fatigue) 
Visual acuity 
Outpatients 
Station stability (eyes closed) 
Foot speed (also fatigue) 
Foot strength 
Toe vibration sense 
Hand speed 
Station (eyes open) 
Hand speed fatigue 
Deltoid strength 
Wrist strength 
Hip strength (also fatigue) 
Finger two point discrimination 
Finger vibration sense 
Hand coordination (also fatigue) 
Grip strength (also fatigue) 
Visual acuity 
become more valid when we are better able to define what is normal function. It 
is reasonable to use the data obtained by WWT, however, for the following 
reasons: he examined all the multiple sclerosis patients, the data are based on our 
latest definition of the neurological tests, and they are in reasonable agreement 
with other data on college students (see TABLES 6, 7 and 8). The objections to the 
WWT data as normal for the multiple sclerosis patients are as follows: The 
sample size is small (eight patients), the individuals were all right-handed, they 
were all males, and since they were all college students they probably represent a 
select stratum of the population, different from the multiple sclerosis patients. 
The visual acuity data in TABLE 12 show no significant abnormalities in the 
outpatient group. On the other hand, the inpatient group had 10 per cent of 
patients who were abnormal. 
The remainder of the data for the test battery are presented in TABLES 13 and 
14. It can be seen that all functions tested are unusually abnormal when compared 
to the normal results. Inspection of the coefficients of variation for the two multiple 
sclerosis groups showed a marked increase over the values which we found in 
normal individuals. For example, note speed of foot: the coefficient of variation 
was 1 1  per cent for normal individuals and 57 per cent for both in- and outpatients. 
This is an expected result, since some of the patients have practically normal foot 
speed and others may have practically none. 
It was of great interest to note that the fatigue tests we have designed (hand 
speed, hand coordination, grip strength, foot speed and hip flexor strength) did 
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not show as much fall-off as expected when compared to the normal data. No 
experiments have been designed to explain for this unexpected finding. 
The data in TABLE 15 summarizes some of the data presented in TABLES 12, 13 
and 14. It should be noted that 90-100 per cent of patients had difficulty with their 
lower extremities (station stability [eyes open and closed], foot speed [also fatigue] 
and strength). On the other hand, visual acuity and grip strength (also fatigue) was 
least affected (0-30 per cent). We are concluding from these data that the high inci- 
dence of abnormality of some tests in the proposed test battery should suggest that 
they are appropriate to evaluate quantitatively the neurological status of multiple 
sclerosis patients. 
In view of the fact that abnormalities can be discovered with the proposed test 
battery the following questions arise: Are they important functional abnormalities 
in relation to daily tasks of living? Are we quantitating important functions or are 
we evaluating “bits” that do not indicate integrated neurological function? Since 
we cannot answer these questions now with our limited experience, we have carried 
out the classical neurological examination on all patients and summarized this in 
terms of Kurtzke’s scores. 
An experiment was designed to provide information on the extent of learning 
and fatigue associated with repeated testing of patients with multiple sclerosis. 
The 10 multiple sclerosis outpatients were examined once a week for three weeks. 
The time-response curve analysis5* was used to test the following hypothesis: 
there were no significant linear regression (learning or fatigue) trends over the 
period of the three examinations. The following tests were found to show a 
significant learning effect from the first to the third examination: hand coordina- 
tion fatigue (1 19 per cent of original); grip strength fatigue (1 10 per cent); finger 
two-point discrimination (1 10 per cent); and in the lower extremity only hip flexor 
strength and fatigue (121 and 137 per cent of original, respectively). No tests had a 
significant fatigue trend from the first to the third examination. 
If we would decide arbitrarily that a change to below 80 or above 120 per cent 
of original values were a technically significant difference, then only the hip 
flexor strength and fatigue have increased significantly from the first to the third 
examination; this result is similar to that found in normal individuals where the 
hip flexor strength test increased to 121 per cent of the original value after more 
vigorous repetitive testing (see TABLE 9). 
We have concluded from this limited study on 10 multiple sclerosis outpatients 
that the proposed test battery is not affected by weekly repetition of examinations, 
except hip flexor strength and hip flexor strength fatigue which improve with 
repetitive testing; these results are similar to more extensive studies on normal 
individuals. 
It would appear from these studies on ambulatory multiple sclerosis patients 
that we can use the proposed battery of tests in a short term therapeutic trial (up 
to three weeks) and probably can use it to follow the course of the disease on a 
long term basis (years). It has also occurred to us that it might be possible 
to determine the depth of a relapse if pre-relapse quantitative testing had been 
carried out; we have had one patient (M.G.) which illustrated this usage of 
the test battery. 
Therapeutic Trial 
A study which used the proposed battery of quantitative neurological tests in a 
therapeutic trial in multiple sclerosis was carried out for one year, July 1962 
to June 1963; 40 patients were selected by preprinted criteria for the therapeutic 
trial;3 the design of the experiment was presented in the section entitled METHODS. 
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When the data obtained from the five treatment groups were analyzed statisti- 
cally by the paired Student t test no differences (p > 0.05) between the neurologic 
tests obtained on the first examination (no drug) and the second examination 
(high dosage for one week) and/or third examination (dosage tapered to zero over 
one week period) were discovered. 
The data obtained from the five treatment groups also were analyzed statistically 
by the analysis of variance techniques. It was found that the patients assigned at 
random to the five treatment groups were not significantly different in their mean 
performance for each of the neurologic tests before the administration of the 
drugs (examination one) except for a technically significant difference for foot 
strength. Furthermore, average hand speed was significantly increased in the group 
treated with MedrolB after the second examination, but this difference did not hold 
up after the medication was decreased (third examination). 
Based on the above results the bio-statistician in this study, Jan W. Kuzma, 
recommended the following: “It appears that there are trends and that real 
differences may be discovered, if they exist, if the sample size for each group 
would be about 25. This would be another 60 patients assigned at random to the 
five groups. Then this type of analysis should be performed again.” At the rate we 
admitted patients to this study it would take another 18 months. Perhaps a coop- 
erative study among several neurological centers should be considered in order to 
expedite this type of study. 
Since this recommendation could not be carried out, the data were reanalyzed 
in a different way. First, patients treated with Solu-medrol,@’ Medrol@ and Alpha- 
drol@ were combined and relabeled steroid treatment group; the three treatment 
groups were now vitamin B,,, seven patients; DEPO-ACTH,@ eight patients; and 
steroids, 25. This is a reasonable manipulation in view of the fact that the three 
synthetic adreno-cortoids probably have an identical mechanism of action. Second, 
the right and left sided data were combined; rather than compare right to right 
and left to left. This may be a reasonable procedure, since multiple sclerosis is an 
asymmetrical (patchy) affliction and therefore one could make the assumption that 
right and left-sided may not be dependent. Third, the right and left-sided data for 
a given neurological test at the initial examination for a given treatment were then 
stratified into results which were within normal range (mean of W.W.T. 2 2 
standard deviations) or subnormal. These two groups of data were then compared 
by the paired Student t test to results obtained for examination 2, as well as ex- 
amination 3. The separation of the data into normal function versus subnormal 
function has some merit; it is reasonable to assume that a patient who has normal 
hand speed will not improve further, whereas diseased tracts which affect hand 
speed and hence result in a subnormal hand speed are more likely to have a 
favorable treatment response. In other words, if the data which are least likely to 
be affected are removed prior to statistical analysis, the statistical tool becomes 
more powerful and hence is likely to discover smaller but real changes. 
The results of combining the data and the statistical analyses for each test and 
each treatment group are shown in TABLE 16; 5 5  statistical differences were 
discovered; however, we arbitrarily decided that any change to a value between 80 
to 120 per cent of the initial examination was only a technically statistical differ- 
ence. The underlined data in the table were “neurologically,” as well as statistically 
significant; there were 32 differences. There may be a pattern to the data. All 
changes were in the direction of improvement except toe vibration in the vitamin 
B,, group for the second examination. Also, more significant improvements were 
discovered in the lower extremities than in the upper extremities; in the upper 
extremities none of the “neurological,” as well as statistical improvements were 
found in both examination 2 and 3. whereas in the lower extremities this was the 
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rule. In the lower extremity vitamin B,, improved two functions on both examina- 
tions, namely, station stability (eyes open) and speed of foot; ATCH improved 
four different functions, namely, foot speed fatigue, foot strength, hip flexor 
strength and fatigue; and steroids improved the same two as vitamin B,,, as well 
as those improved by ACTH. If these are significant neurological improvements, 
it would appear that steroids and probably ACTH do more than vitamin BIZ; 
other than the improvements in station stability (eyes open) and foot speed which 
may be the placebo effect; foot speed fatigue, hip flexor strength and hip flexor 
strength fatigue may improve to 124 to 196 per cent of the first examination when 
the patient is on ACTH or steroids. 
We also analyzed the test results which fell into the normal range for the three 
treatments in a manner similar to that mentioned above; there were only three 
values which were considered “neurologically” and statistically significant. They 
occurred only in the steroid group. They were as follows: hip flexor strength 
126 per cent exam 1 versus exam 2 and hip flexor strength fatigue, 121 and 124 
per cent, exam 1 versus 2, and exam 1 versus 3, respectively. These data confirm 
our previously stated impression that test results which fall into the normal range 
are unlikely to be improved by treatment. 
Because of the above results and those reported by Kibler” in this symposium, 
we reworked the data again. We went through the clinical records of the patients 
used in this therapeutic trial and chose those patients who stated they had a 
significant weakness in the lower extremities less than two months before the 
initial examination in the therapy study. Furthermore, the patient had to have 
normal to subnormal function prior to the relapse; he had to be able to walk at 
least one block without the aid of appliances. Three patients in the Depo-ACTH,@ 
and nine patients in the steroid group (Solu-Medrol,@ Medrol,@ or AlphadroP) 
were admitted to this study; unfortunately no patients in the vitamin B,, group 
were accepted. 
The data shown in TABLE 17 included only those improvements which were 
neurologically significant, i.e. the paired Student t test from one examination 
to another had to indicate a significant difference (p < 0.05) and then the change 
had to fall outside of 80-120 per cent of the original values. The improvements fit 
about the same pattern as gleaned from the data presented in TABLE 16; i.e. most 
of the improvement was in the function of the lower extremities; however, some of 
the tests do show much greater improvement. No test results significantly worsened 
during the course of this therapeutic trial. 
The patients were also rated neurologically according to the system recom- 
mended by Kurtzke.’ In most cases the patients did not change their total disability 
score or systems score from one examination to another, even though it was obvious 
by clinical neurological examination and quantitative neurological examination 
that the patient was better. 
It was our impression that this therapeutic trial warrants continuation; more 
patients should be obtained to determine whether the improvements produced by 
ACTH and steroids are better than a vitamin treatment (vitamin BIZ). 
In TABLE 18 are recorded the special conditions occurring in the patients during 
the study period. Nothing serious was observed, even though the steroid dosages 
were very large. 
There are many objections to the therapeutic trial which we have conducted so 
far. It is obvious that more patients must be studied; perhaps the battery of tests 
proposed is irrelevant; and maybe a different dosage schedule should be used. 
If a significant neurological improvement is established, it will then be necessary 
to determine whether this improvement is related to the pathogenesis of multiple 
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Treatment Exam 1 
Tests* Group Mean (C.V. %) 
I I I I 
Exam 1 vs. 2 Exam 1 vs. 3 
per cent of original per cent of original 
function, if function, if 
significant significant 
Hand coordination 1 Steroid I 18(27) I 135 1 135 
I I I I 
Grip strength fatigue 1 ACTH 1 29(135) I 147 1 123 
I Steroid 1 7(48) I 137 I 172 Station stability 
(Eyes open) 
250 
210 125 1 129 ACTH Hip flexor strength 1 Steroid I liE1 I 
1 Steroid I 13(57) I 184 193 Hip flexor strength 
fatigue 
Foot strength 1 ACTH 1 21(82) 1 166 I 195 
21 (48) 
Foot speed I cE: 1 6(130) 
I i t 
Foot speed fatigue I I 16(38) 
3(171) I 
Toe vibration 1 Steroid 1 32(120) 1 73 I N.S. 
*Units for the test are the same as shown in TABLE 16. 
SUMMARY 
Evidence has been presented that certain neurological functions in normals and 
ambulatory patients with multiple sclerosis are measurable quantities (visual 
acuity, 10 upper extremity functions and eight lower extremity functions). There 
was no significant learning or fatigue effect on repetitive testing except hip flexor 
strength. The battery of tests were teachable to para-medical personnel. 
The therapeutic trial which was conducted has not shown any significant dif- 
ferences between vitamin B,,, Depo-Acth,@ Solu-Medrol,@ Medroln and Alpha- 
drol; @ however, if only patients with subnormal function were analyzed, a number 
of significant differences especially in the lower extremities, were discovered in the 
ACTH and steroid groups, and fewer in the vitamin B,, group. More patients will 
have to be studied to determine if the significant differences discovered are not the 
result of sampling errors. 
ACKNOWLEDGMENTS 
Some aspects of this study were considered by J. W. Kuzma in his dissertation 
as a partial fulfillment of the requirements for doctor of philosophy in the Depart- 
ment of Biostatics, University of Michigan. 
504 Annals New York Academy of Sciences 
TABLE 17 
TESTS CARRIED OUT IN THE THERAPEUTIC RIAL OF THOSE PATIENTS JUDGED TO 
HAVE A RELAPSE OF WEAKNESS IN THE LOWER EXTREMITIES 
SUMMARY OF THE RESULTS AND THE STATISTICAL ANALYSES OF THE BATTERY OF 





0 -1 -5 -5 -4 
12: 0 0 0 0 
TABLE 18 
SPECIAL CONDITIONS OBSERVED IN PATIENTS DURING STUDY PERIOD 
Special Vitamin Depo- 
Conditions 1 B,, 1 ACTHO I Soh-Medrol" 
Moon-face 
*% of patients in group. 
**1 Abscess injection site; 13th day. 
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